(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are SODITECH, ASETEK, and ARCHER.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| SODITECH (SEC.PA) | 1.64 | 15.49% | 2023-04-13 11:03:24 |
| ASETEK (ASTK.OL) | 9.20 | 10.84% | 2023-04-13 11:20:23 |
| ARCHER (ARCH.OL) | 1.07 | 8.74% | 2023-04-13 11:20:15 |
| WILSON (WILS.OL) | 68.80 | 7.5% | 2023-04-13 11:35:10 |
| HYDROGENPRO (HYPRO.OL) | 23.75 | 6.5% | 2023-04-13 11:30:32 |
| FUGRO (FUR.AS) | 12.64 | 6.4% | 2023-04-13 11:02:27 |
| DMS IMAGING (DMSIM.BR) | 0.03 | 6.25% | 2023-04-13 11:06:47 |
| AB SCIENCE (AB.PA) | 6.45 | 6.09% | 2023-04-13 11:35:22 |
| MEMSCAP REGPT (MEMS.PA) | 3.15 | 6.06% | 2023-04-13 11:00:16 |
| GROUPE SFPI (SFPI.PA) | 2.49 | 5.96% | 2023-04-13 11:50:06 |
The three biggest losers today are SAS AB, TGS, and PGS.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| SAS AB (SASNO.OL) | 0.22 | -12.02% | 2023-04-13 11:33:16 |
| TGS (TGS.OL) | 181.40 | -8.34% | 2023-04-13 11:34:36 |
| PGS (PGS.OL) | 9.03 | -6.47% | 2023-04-13 11:32:41 |
| GENEURO (GNRO.PA) | 1.85 | -6.09% | 2023-04-13 11:49:40 |
| CELYAD ONCOLOGY (CYAD.BR) | 0.71 | -6.08% | 2023-04-13 11:06:17 |
| BENEVOLENTAI (BAI.AS) | 2.22 | -5.93% | 2023-04-13 11:01:01 |
| TECHSTEP (TECH.OL) | 1.26 | -5.64% | 2023-04-13 11:34:30 |
| ITERA (ITERA.OL) | 13.20 | -5.38% | 2023-04-13 11:30:43 |
| INVENTIVA (IVA.PA) | 2.57 | -5.34% | 2023-04-13 11:50:47 |
| PASSAT (PSAT.PA) | 4.10 | -5.09% | 2023-04-13 08:01:25 |
Winners today
1. SODITECH (SEC.PA)
15.49% Price Change
Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.
CAC 40 ended the session with SODITECH rising 15.49% to €1.64 on Thursday, after four consecutive sessions in a row of losses. CAC 40 jumped 1.13% to €7,480.83, after three consecutive sessions in a row of gains, on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, SODITECH has a trailing twelve months EPS of €0.41.
PE Ratio
SODITECH has a trailing twelve months price to earnings ratio of 4. Meaning, the purchaser of the share is investing €4 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.66%.
Yearly Top and Bottom Value
SODITECH’s stock is valued at €1.64 at 22:40 EST, below its 52-week high of €1.73 and way higher than its 52-week low of €0.71.
Volume
Today’s last reported volume for SODITECH is 212 which is 70.91% below its average volume of 729.
More news about SODITECH.
2. ASETEK (ASTK.OL)
10.84% Price Change
Asetek A/S, together with its subsidiaries, engages in the designing, developing, and marketing of liquid cooling solutions in Asia, Europe, and the Americas. The company operates in two segments, Gaming and Enthusiast; and Data Center. Its products are used in personal computers, servers, and data centers to provide improved performance, acoustics, and energy efficiency. It serves original equipment manufacturers, resellers, and channel partners. Asetek A/S was founded in 1997 and is headquartered in Aalborg, Denmark.
Oslo Børs Benchmark Index_GI ended the session with ASETEK rising 10.84% to €9.20 on Thursday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.04% to €1,216.15, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, ASETEK has a trailing twelve months EPS of kr-3.29.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ASETEK’s stock is considered to be overbought (>=80).
More news about ASETEK.
3. ARCHER (ARCH.OL)
8.74% Price Change
Archer Limited, an oilfield service company, provides various oilfield products and services to the oil and gas industry. The company operates through two segments, Eastern Hemisphere and Western Hemisphere. It provides oiltools, such as plugs and abandonment (P&A), slot recovery and P&A, cementing, and well cleaning solutions; digital well integrity solutions; land drilling and platform drilling services; mobile offshore drilling unit management services; and modular drilling rigs. The company also offers engineering services, such as project management, construction and installations, multidiscipline engineering, consulting, and inspection services. In addition, it provides wireline services, including cased hole logging, conveyance and mechanical/slickline, research and development, and technology development services. Further, the company offers equipment rental, production monitoring, well imaging, and integrity management tools services. It operates in North America, South America, Europe, and internationally. The company was formerly known as Seawell Limited and changed its name to Archer Limited in May 2011. Archer Limited was incorporated in 2007 and is based in Sandnes, Norway.
Oslo Børs Benchmark Index_GI ended the session with ARCHER jumping 8.74% to €1.07 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,216.15, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, ARCHER has a trailing twelve months EPS of kr-0.51.
More news about ARCHER.
4. WILSON (WILS.OL)
7.5% Price Change
Wilson ASA operates as a shipping company in Europe. The company engages in the ship chartering and operation; ship management; marine accounting; crewing; purchasing; legal; and insurance activities. It operates through a fleet of 130 vessels in the range of 1500 to 8500 DWT. The company was founded in 1929 and is headquartered in Bergen, Norway. Wilson ASA operates as a subsidiary of Caiano AS.
Oslo Børs Benchmark Index_GI ended the session with WILSON rising 7.5% to €68.80 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.04% to €1,216.15.
Earnings Per Share
As for profitability, WILSON has a trailing twelve months EPS of kr21.84.
PE Ratio
WILSON has a trailing twelve months price to earnings ratio of 3.15. Meaning, the purchaser of the share is investing kr3.15 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.99%.
Yearly Top and Bottom Value
WILSON’s stock is valued at kr68.80 at 22:40 EST, way below its 52-week high of kr79.00 and way above its 52-week low of kr56.20.
More news about WILSON.
5. HYDROGENPRO (HYPRO.OL)
6.5% Price Change
HydrogenPro AS designs and supplies customized hydrogen plants for industrial clients. The company primarily provides alkaline high-pressure electrolysers. It also offers containerized solutions for small plants; and indoor installations for medium plants. The company was incorporated in 2013 and is headquartered in Porsgrunn, Norway.
Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO jumping 6.5% to €23.75 on Thursday while Oslo Børs Benchmark Index_GI rose 0.04% to €1,216.15.
Earnings Per Share
As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.14%.
Yearly Top and Bottom Value
HYDROGENPRO’s stock is valued at kr23.75 at 22:40 EST, way under its 52-week high of kr40.10 and way above its 52-week low of kr15.98.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYDROGENPRO’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 128.5%, now sitting on 56.41M for the twelve trailing months.
More news about HYDROGENPRO.
6. FUGRO (FUR.AS)
6.4% Price Change
Fugro N.V. provides geo-data information through integrated data acquisition, analysis, and advice for infrastructure, energy, and water industries worldwide. It offers marine geo-consulting, marine geo-technics, geo-physical survey, metocean surveys, marine environmental, and hydrographic survey services. The company also provides geo-technical ground investigation, geological and geophysical survey, nearshore geotechnical site investigation, testing and monitoring, environmental site characterization and remediation, water consultancy services, and geo consulting services. In addition, it offers marine asset integrity services, including positioning and construction support, satellite positioning, monitoring and forecasting, remotely operated vehicle services and tooling, and marine infrastructure solutions, as well as inspection, repair and maintenance services. Further, the company provides land asset integrity services, such as digital plant and pipelines, surveying and mapping, raildata, roadware surveys, Roames power, and land weather forecasting services. It serves in Europe, Africa, the Americas, the Asia Pacific, the Middle East, and India. The company was incorporated in 1962 and is based in Leidschendam, the Netherlands.
AEX-Index ended the session with FUGRO rising 6.4% to €12.64 on Thursday while AEX-Index jumped 0.14% to €760.57.
Earnings Per Share
As for profitability, FUGRO has a trailing twelve months EPS of €0.71.
PE Ratio
FUGRO has a trailing twelve months price to earnings ratio of 17.8. Meaning, the purchaser of the share is investing €17.8 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.23%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.3%, now sitting on 1.77B for the twelve trailing months.
Yearly Top and Bottom Value
FUGRO’s stock is valued at €12.64 at 22:40 EST, way under its 52-week high of €15.10 and way higher than its 52-week low of €9.63.
More news about FUGRO.
7. DMS IMAGING (DMSIM.BR)
6.25% Price Change
DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen. The company is also developing hdm-ASIT+ for the treatment of house dust mite allergy; and pnt-ASIT+ for the treatment of peanut allergy. The company was formerly known as ASIT Biotech S.A. and changed its name to DMS Imaging SA in February 2022. DMS Imaging SA was incorporated in 1997 and is based in Liege, Belgium.
BEL 20 ended the session with DMS IMAGING rising 6.25% to €0.03 on Thursday, following the last session’s downward trend. BEL 20 jumped 0.3% to €3,812.93, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, DMS IMAGING has a trailing twelve months EPS of €0.17.
PE Ratio
DMS IMAGING has a trailing twelve months price to earnings ratio of 0.15. Meaning, the purchaser of the share is investing €0.15 for every euro of annual earnings.
Volume
Today’s last reported volume for DMS IMAGING is 22660 which is 88.84% below its average volume of 203183.
Volatility
DMS IMAGING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.13%, a negative 1.88%, and a positive 5.10%.
DMS IMAGING’s highest amplitude of average volatility was 2.13% (last week), 4.49% (last month), and 5.10% (last quarter).
More news about DMS IMAGING.
8. AB SCIENCE (AB.PA)
6.09% Price Change
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
CAC 40 ended the session with AB SCIENCE rising 6.09% to €6.45 on Thursday, following the last session’s downward trend. CAC 40 rose 1.13% to €7,480.83, after three consecutive sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.35.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AB SCIENCE’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
AB SCIENCE’s stock is valued at €6.45 at 22:40 EST, way under its 52-week high of €11.19 and way above its 52-week low of €5.48.
More news about AB SCIENCE.
9. MEMSCAP REGPT (MEMS.PA)
6.06% Price Change
MEMSCAP, S.A. provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical and biomedical, and IT/consumer markets worldwide. The company offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. It also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories; and magnetic switches/relays, as well as supplies implantable pressure sensors for spinal pressure monitoring, abdominal aortic aneurism, etc. In addition, the company supplies optical MEMS chips for variable optical attenuators in optical telecommunication markets; and provides the multi-user MEMS processes (MUMPs) comprising PolyMUMPs, SOIMUMPs, and PiezoMUMPs, as well as MUMPs-PLUS and post processing services. Further, it offers custom products, including wafers, MEMS dies, and wafer level packaged devices; and manufacturing services, as well as prototyping services. The company sells its products and services to Fortune 500 companies, high-technology industries, research institutes, and universities. MEMSCAP, S.A. was founded in 1997 and is headquartered in Crolles, France.
CAC 40 ended the session with MEMSCAP REGPT rising 6.06% to €3.15 on Thursday, after two successive sessions in a row of gains. CAC 40 rose 1.13% to €7,480.83, after three successive sessions in a row of gains, on what was an all-around bullish trend exchanging session today.
Volume
Today’s last reported volume for MEMSCAP REGPT is 37181 which is 33.84% above its average volume of 27780.
More news about MEMSCAP REGPT.
10. GROUPE SFPI (SFPI.PA)
5.96% Price Change
GROUPE SFPI SA designs, manufactures, and markets equipment for the safety industry in Europe and internationally. The company operates through DOM Security, NEU-JKF, MMD, MAC, and Other Businesses divisions. It offers opening and closure systems, such as windows and carpentry, blinds and shutters, awnings, front and garage doors, and industrial closures for housing and industrial buildings under the France Fermetures, Franciaflex, Faber, or SIPA Menuiseries brands. The company also provides mechanical and digital locking solutions for home owners, small businesses, and large organizations; and locking equipment for industrial groups. In addition, it offers air treatment solutions, such as de-dusting systems, filtration and air conditioning, pneumatic conveying of production waste, pneumatic conveying, industrial fans, etc. for food, agro-milling, wood, chemistry, cement, glass, minerals and metals, paperboard and paper, can, nuclear, plastic, aeronautics, and automotive industries. Further, the company provides thermal processing and sterilization solutions for food, chemistry, heavy, and other industries. GROUPE SFPI SA was founded in 1985 and is headquartered in Paris, France.
CAC 40 ended the session with GROUPE SFPI rising 5.96% to €2.49 on Thursday, after two successive sessions in a row of gains. CAC 40 rose 1.13% to €7,480.83, after three consecutive sessions in a row of gains, on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, GROUPE SFPI has a trailing twelve months EPS of €0.28.
PE Ratio
GROUPE SFPI has a trailing twelve months price to earnings ratio of 8.89. Meaning, the purchaser of the share is investing €8.89 for every euro of annual earnings.
Volatility
GROUPE SFPI’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.87%, a negative 0.73%, and a positive 1.46%.
GROUPE SFPI’s highest amplitude of average volatility was 1.87% (last week), 1.68% (last month), and 1.46% (last quarter).
Volume
Today’s last reported volume for GROUPE SFPI is 20137 which is 27.8% above its average volume of 15756.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GROUPE SFPI’s stock is considered to be oversold (<=20).
More news about GROUPE SFPI.
Losers Today
1. SAS AB (SASNO.OL)
-12.02% Price Change
SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 135 aircraft, including 12 long-haul aircraft, 95 short-haul aircraft, and 28 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Oslo Børs Benchmark Index_GI ended the session with SAS AB dropping 12.02% to €0.22 on Thursday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,216.15, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, SAS AB has a trailing twelve months EPS of kr-0.7.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1151.97%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SAS AB’s EBITDA is 1.2.
Volatility
SAS AB’s last week, last month’s, and last quarter’s current intraday variation average was a negative 27.54%, a negative 3.71%, and a positive 2.48%.
SAS AB’s highest amplitude of average volatility was 27.54% (last week), 4.54% (last month), and 2.48% (last quarter).
Yearly Top and Bottom Value
SAS AB’s stock is valued at kr0.22 at 22:40 EST, way below its 52-week low of kr0.41.
More news about SAS AB.
2. TGS (TGS.OL)
-8.34% Price Change
TGS ASA provides geoscience data products and services to the oil and gas industry worldwide. The company offers geophysical multi-client data, including seismic data; and geophysical library, such as gravity, magnetic, seep, geothermal, controlled source electromagnetic, and multibeam data. It also provides geological services comprising digital well logs; and interpretation products and data integration solutions. In addition, the company offers imaging services, which include depth and time imaging; marine, land, and ocean bottom cables and nodes; anisotropic imaging; transition zone processing; multi component processing; shear wave; and 4D time-lapse, as well as wide azimuth data processing. Further, it provides data and analytics solutions; and PRIMA, a multifunction exploration software suite. The company was formerly known as TGS-NOPEC Geophysical Company ASA and changed its name to TGS ASA in June 2021. TGS ASA was founded in 1981 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with TGS sliding 8.34% to €181.40 on Thursday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,216.15, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, TGS has a trailing twelve months EPS of kr-2.95.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.74%.
Moving Average
TGS’s value is above its 50-day moving average of kr175.12 and way higher than its 200-day moving average of kr150.19.
More news about TGS.
3. PGS (PGS.OL)
-6.47% Price Change
PGS ASA, together with its subsidiaries, operates as a marine geophysical company primarily in Norway. The company provides a range of seismic and reservoir services, including data acquisition, imaging, interpretation, and field evaluation to oil and gas companies, as well as carbon storage and offshore wind markets. It also operates in the Asia Pacific, Canada, Egypt, the Americas, Angola, the United Kingdom, Greece, Cyprus, Ukraine, Brazil, South Africa, other African countries, the Middle East, and internationally. The company was formerly known as Petroleum Geo-Services ASA and changed its name to PGS ASA in May 2019. PGS ASA was founded in 1991 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PGS falling 6.47% to €9.03 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,216.15, after two sequential sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, PGS has a trailing twelve months EPS of kr-0.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.68%.
Sales Growth
PGS’s sales growth is 49.3% for the current quarter and negative 22.7% for the next.
Volatility
PGS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.32%, a negative 1.45%, and a positive 3.88%.
PGS’s highest amplitude of average volatility was 0.63% (last week), 5.07% (last month), and 3.88% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 109.4% and 31%, respectively.
More news about PGS.
4. GENEURO (GNRO.PA)
-6.09% Price Change
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical trial for multiple sclerosis; and is in Phase IIa to treat type 1 diabetes, as well as is in Phase I for the treatment of chronic inflammatory demyelinating polyneuropathy. It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic centers to develop inflammatory psychosis, as well as a research collaboration agreement with International Center for Infectiology Research; and with Northwestern University for human endogenous retrovirus W envelope protein (HERV-W ENV) in long-haul COVID patients. The company was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
CAC 40 ended the session with GENEURO sliding 6.09% to €1.85 on Thursday while CAC 40 jumped 1.13% to €7,480.83.
Earnings Per Share
As for profitability, GENEURO has a trailing twelve months EPS of €-0.35.
Volatility
GENEURO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.77%, a negative 2.84%, and a positive 4.53%.
GENEURO’s highest amplitude of average volatility was 1.80% (last week), 4.47% (last month), and 4.53% (last quarter).
Volume
Today’s last reported volume for GENEURO is 7766 which is 2.87% below its average volume of 7996.
More news about GENEURO.
5. CELYAD ONCOLOGY (CYAD.BR)
-6.08% Price Change
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. The company's preclinical candidate includes CYAD-203, a non-gene edited allogeneic CAR-T candidate to co-express the cytokine interleukin-18 with natural killer group 2D ligands (NKG2D) for the treatment of solid tumors. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA technology to generate second non-gene-edited allogeneic platform. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with CELYAD ONCOLOGY sliding 6.08% to €0.71 on Thursday while BEL 20 rose 0.3% to €3,812.93.
Earnings Per Share
As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.69.
Volume
Today’s last reported volume for CELYAD ONCOLOGY is 107988 which is 8.15% below its average volume of 117580.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CELYAD ONCOLOGY’s stock is considered to be overbought (>=80).
More news about CELYAD ONCOLOGY.
6. BENEVOLENTAI (BAI.AS)
-5.93% Price Change
BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.
AEX-Index ended the session with BENEVOLENTAI sliding 5.93% to €2.22 on Thursday, following the last session’s upward trend. AEX-Index jumped 0.14% to €760.57, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-1.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.13%.
More news about BENEVOLENTAI.
7. TECHSTEP (TECH.OL)
-5.64% Price Change
Techstep ASA operates as a mobile technology enabler in Norway, Sweden, Denmark, and Poland. It offers mobile hardware, service, support, and mobility consultancy services; software as a service, as well as mobile expense management modules; and financing and remarketing services. The company also provides industry-leading cloud-based PBX solutions and enterprise mobility management services, including mobile security, system design, implementation, and mobile device management. In addition, it develops and provides enterprise mobility software and solutions for the customers in the transportation, logistics, and public safety sectors, as well as offers mobile device lifecycle management solutions. The company was founded in 2016 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with TECHSTEP sliding 5.64% to €1.26 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.04% to €1,216.15.
Earnings Per Share
As for profitability, TECHSTEP has a trailing twelve months EPS of kr-0.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.18%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TECHSTEP’s stock is considered to be oversold (<=20).
More news about TECHSTEP.
8. ITERA (ITERA.OL)
-5.38% Price Change
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ITERA sliding 5.38% to €13.20 on Thursday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.04% to €1,216.15, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.51.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 25.88. Meaning, the purchaser of the share is investing kr25.88 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 138.07%.
More news about ITERA.
9. INVENTIVA (IVA.PA)
-5.34% Price Change
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.
CAC 40 ended the session with INVENTIVA falling 5.34% to €2.57 on Thursday, after four sequential sessions in a row of losses. CAC 40 rose 1.13% to €7,480.83, after three sequential sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, INVENTIVA has a trailing twelve months EPS of €-1.19.
Volatility
INVENTIVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.46%, a negative 2.43%, and a positive 2.30%.
INVENTIVA’s highest amplitude of average volatility was 2.46% (last week), 3.06% (last month), and 2.30% (last quarter).
Volume
Today’s last reported volume for INVENTIVA is 83656 which is 156.94% above its average volume of 32558.
More news about INVENTIVA.
10. PASSAT (PSAT.PA)
-5.09% Price Change
Passat Société Anonyme engages in the image-assisted sale of consumer products in France. The company sell household, kitchen, DIY, garden, beauty, and leisure and fitness products. Passat Société Anonyme was founded in 1987 and is headquartered in Fourqueux, France.
CAC 40 ended the session with PASSAT falling 5.09% to €4.10 on Thursday, after two sequential sessions in a row of gains. CAC 40 jumped 1.13% to €7,480.83, after three sequential sessions in a row of gains, on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, PASSAT has a trailing twelve months EPS of €0.06.
PE Ratio
PASSAT has a trailing twelve months price to earnings ratio of 68.33. Meaning, the purchaser of the share is investing €68.33 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.55%.
Yearly Top and Bottom Value
PASSAT’s stock is valued at €4.10 at 22:40 EST, way below its 52-week high of €5.52 and higher than its 52-week low of €4.08.
Moving Average
PASSAT’s worth is way under its 50-day moving average of €4.92 and way under its 200-day moving average of €4.80.
Volume
Today’s last reported volume for PASSAT is 100 which is 91.43% below its average volume of 1167.
More news about PASSAT.
Stay up to date with our winners and losers daily report
